Microglial activation in early stages of amyloid β protein deposition
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The present study was undertaken to investigate the relationship of microglial activation to amyloid beta protein (A beta) deposition, particularly at the early stage. Using single and double immunostaining methods with a panel of microglia markers and antibodies against A beta and amyloid beta protein precursor (APP), we examined the cerebrum and cerebella of both Alzheimer's disease (AD) and non-demented subjects obtained at autopsy. In nondemented, middle-aged subjects that had small amounts of cerebral A beta deposits, approximately 70% of the diffuse plaques contained ramified microglia. However, no evidence of microglial activation was found in diffuse plaques in any of the non-demented subjects. Dual immunostaining of sections of cerebral cortex using antibodies against A beta and major histocompatibility complex class II antigen showed that in AD subjects, approximately 20% of total diffuse plaques contained a few, activated microglia. Most of these plaques were defined as a transitional from between diffuse and primitive plaques. Both primitive and classic plaques in the cerebral cortex of AD subjects consistently contained clusters of activated microglia. Subpial A beta deposits without neuritic changes lacked microglial activation. In the cerebellum, all of the diffuse plaques lacked microglial activation, and activated microglia in the compact plaques were not as hypertrophic as those in cerebral primitive/classic plaques. Our findings indicate that microglial reactions are absent in the early stages of A beta deposition, and it occurs during the transition from diffuse to primitive plaques, when amounts of A beta deposits and the degree of neuritic changes increase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, early, non-fibrillar diffuse plaques are associated with little or no microglial clustering (53) and accumulate little or no complement proteins (8, 9).”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [53]
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 1×
“A β is derived from a larger membrane-bound protein, amyloid β protein precursor (APP) [ 11 ].”
BackgroundDiagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Microglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,119 · cited 1×
“Microglial activation takes place in a graded fashion: first, activated microglia become hypertrophic with increased expression of several marker molecules (such as MHC antigens); second, phagocytic microglia continue to swell and express additional marker molecules characteristic of peripheral macrophages [ 7 ].”
BackgroundRelationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940 · cited 1×
“In a large number of immunohistochemical studies, activated microglia have been found to be clustered in congophilic plaques, but not in diffuse plaques [1, 3, 10 , 13, 20, 30].”
BackgroundAmyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
Rumble, B., Retallack, R., Hilbich, C., Simms, G., Multhaup, G., Martins, R., Hockey, A., Montgomery, P., Beyreuther, K., & Masters, C. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906013202203 · Cited by 653 · cited 1×
“syndrome patients as well as in middle-aged, non-demented individuals may represent the earliest stage of A β deposition [ 25 , 29].”
BackgroundT. Griffin, W. S., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 549
Yamaguchi, H., Hirai, S., Morimatsu, M., Shoji, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00689591 · Cited by 283
Self-citationFrackowiak, J., Wisniewski, H. M., Wegiel, J., Merz, G. S., Iqbal, K., & Wang, K. C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227813 · Cited by 276
MHC class II‐positive microglia in human brain: Association with alzheimer lesions
Perlmutter, L. S., Scott, S. A., Barrón, E., & Chui, H. C. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330407 · Cited by 232 · cited 1×
“Certain characteristics of the microglial markers have already been reported: (1) LN1 reacts mostly with resting microglia [27]; (2) Ki-M1p in resting and reactive microglia is expressed most consistently in formalin-fixed, paraffin-embedded tissues [21, 28]; and (3) LN3 and CR3.43 can be used as markers for activated…”
BackgroundWisniewski, H. M., Wegiel, J., Wang, K. C., & Lach, B. (1992) · Acta Neuropathologica · doi:10.1007/bf00311383 · Cited by 221
Cited by
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
“Ab will both recruit and activate microglia (Davis et al., 1992; Meda et al., 1995; Sasaki et al., 1997), where Ab has been reported to result in the release of neurotoxic factors from microglia, such as NO (Ii et al.”
BackgroundMicroglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727
“2c), which needs an explanation for the many prior observations reporting activated microglia associated with these lesions [30, 35, 38, 39, 41].”
BackgroundComplement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 622
Microglia and inflammatory mechanisms in the clearance of amyloid β peptide
Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R. (2002) · Glia · doi:10.1002/glia.10153 · Cited by 381
“© 2002 Wiley-Liss, Inc. Perlmutter et al., 1992; Sasaki et al., 1997; Overmyer et al., 1999) that microglia in pathologically vulnerable regions of the AD brain profusely express the activation marker major histocompatibility complex class II cell surface glycoprotein (MHCII), increasing attention…”
BackgroundJantzen, P. T., Connor, K. E., DiCarlo, G., Wenk, G. L., Wallace, J. L., Rojiani, A. M., Coppola, D., Morgan, D., & Gordon, M. N. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02246.2002 · Cited by 340
Exercise Plays a Preventive Role Against Alzheimer's Disease
Radak, Z., Hart, N., Sarga, L., Koltai, E., Atalay, M., Ohno, H., & Boldogh, I. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091531 · Cited by 316
“nile, amyloid plaques and neurofibrillary tangles [51].”
Law, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00051-5 · Cited by 314
Brain Extracellular Matrix in Neurodegeneration
Bonneh‐Barkay, D., & Wiley, C. A. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00195.x · Cited by 307
Atwood, C. S., Obrenovich, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., & Martins, R. N. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00174-7 · Cited by 293
Davies, D. S., Ma, J., Jegathees, T., & Goldsbury, C. (2017) · Brain Pathology · doi:10.1111/bpa.12456 · Cited by 251
Rogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236
Di Filippo, M., Sarchielli, P., Picconi, B., & Calabresi, P. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.005 · Cited by 211
Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205
NADPH oxidase as a therapeutic target in Alzheimer's disease
Block, M. L. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s8 · Cited by 204
“Undoubtedly, Aβ has been shown to both recruit and activate microglia [8,14,27], suggesting a critical role in AD progression.”
BackgroundNeumann, A., Schinzel, R., Palm, D., Riederer, P., & Münch, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00731-0 · Cited by 195
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
von Bernhardi, R., & Eugenín, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 190
11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease
Kreisl, W. C., Lyoo, C. H., Liow, J.-S., Wei, M., Snow, J., Page, E., Jenko, K. J., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.011 · Cited by 174
Microglia Demonstrate Age-Dependent Interaction with Amyloid-β Fibrils
Floden, A. M., & Combs, C. K. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101014 · Cited by 162
“They are found in white and grey matter often in intimate association with amyloid- (A ) fibril containing plaques [5–8].”
Expression of Scavenger Receptors in Glial Cells
Alarcón, R., Fuenzalida, C., Santibáñez, M., & von Bernhardi, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414686200 · Cited by 158
Jung, H. W., Yoon, C.-H., Park, K. M., Han, H. S., & Park, Y. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.02.012 · Cited by 167
Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
Moore, A. H., & O’Banion, M. K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00162-x · Cited by 171
Atwood, C., Martins, R. N., Smith, M. A., & Perry, G. L. (2002) · Peptides · doi:10.1016/s0196-9781(02)00070-0 · Cited by 175
Thal, D. R., Schultz, C., Dehghani, F., Yamaguchi, H., Braak, H., & Braak, E. (2000) · Acta Neuropathologica · doi:10.1007/s004010000242 · Cited by 136
“Full-length Aβ deposits presumably induce pathological activation of astrocytes with strong expression of GFAP [7, 8]. These activated astrocytes are closely associated with the Aβ deposits and do not contain intracellular A βpositive material [4, 7, 12, 16, 27 , 28, 32, 38].”
BackgroundResultSelf-citationMicroglia and Alzheimer’s disease
Kalaria, R. N. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199901000-00004 · Cited by 133
Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors
Surace, M. J., & Block, M. L. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1015-4 · Cited by 131
Veerhuis, R., Van Breemen, M. J., Hoozemans, J. J., Morbin, M., Ouladhadj, J., Tagliavini, F., & Eikelenboom, P. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0624-7 · Cited by 123
“Clusters of activated microglia are observed in primitive and classic (dense-cored) plaques in the AD neocortex ([12, 21, 42 ] and this study).”
BackgroundDhawan, G., & Combs, C. K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-117 · Cited by 117
“Amyloid beta deposition and microglial activation are two major pathophysiologic hallmarks of the progression of Alzheimer’s disease, often suggested to be associated with each other [1-9].”
BackgroundPaasila, P. J., Davies, D. S., Kril, J. J., Goldsbury, C., & Sutherland, G. T. (2019) · Brain Pathology · doi:10.1111/bpa.12717 · Cited by 121
Silei, V., Fabrizi, C., Venturini, G., Salmona, M., Bugiani, O., Tagliavini, F., & Lauro, G. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01272-4 · Cited by 112
Serrano-Pozo, A., Qian, J., Muzikansky, A., Monsell, S. E., Montine, T. J., Frosch, M. P., Betensky, R. A., & Hyman, B. T. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw026 · Cited by 105
Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism
Dhawan, G., Floden, A. M., & Combs, C. K. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.027 · Cited by 104
Leoutsakos, J. S., Muthen, B. O., Breitner, J. C. S., & Lyketsos, C. G. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2723 · Cited by 104
“In autopsy studies of normal older individuals,microglia were associated with neuritic but not diffuse plaques (Mackenzie et al., 1995; Sasaki et al., 1997).”
BackgroundAltered microglial copper homeostasis in a mouse model of Alzheimer’s disease
Zheng, Z., White, C., Lee, J., Peterson, T. S., Bush, A. I., Sun, G. Y., Weisman, G. A., & Petris, M. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06888.x · Cited by 101
“This result was entirely consistent with the proliferation and activation of microglia observed around b-amyloid plaques in AD brain (McGeer et al. 1987; Sasaki et al. 1997; Cagnin et al. 2001).”
ResultAstrocyte changes in aging cerebral cortex and hippocampus: A quantitative immunohistochemical study
Amenta, F., Bronzetti, E., Sabbatini, M., & Vega, J. A. (1998) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19981001)43:1<29::aid-jemt5>3.0.co;2-h · Cited by 104
Damjanac, M., Bilan, A. R., Barrier, L., Pontcharraud, R., Cantereau, A., Hugon, J., & Page, G. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.050 · Cited by 114
Microglial reactivity to β-amyloid is modulated by astrocytes and proinflammatory factors
Rommy von Bernhardi, M., & Eugenín, J. L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.084 · Cited by 113
Microglial activation occurs late during preclinical Alzheimer's disease
Streit, W. J., Braak, H., Del Tredici, K., Leyh, J., Lier, J., Khoshbouei, H., Eisenlöffel, C., Müller, W., & Bechmann, I. (2018) · Glia · doi:10.1002/glia.23510 · Cited by 98
“Earlier work has also shown that microglial clustering occurs only in so-called “primitive,” “classic” plaques (Mackenzie, Hao, & Munoz, 1995; Ohgami et al., 1991; Sasaki et al., 1997), which stain positively for Congo Red.”
BackgroundDecline of immune responsiveness: A pathogenetic factor in Alzheimer’s disease?
Richartz, E., Stransky, E., Batra, A., Simon, P. D., Lewczuk, P., Buchkremer, G., BARTELS, M., & Schott, K. J. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.12.005 · Cited by 108
Ko, C., Chang, L.-H., Lee, Y., Sterneck, E., Cheng, C.-P., Chen, S., Huang, A., Tseng, J. T.-C., & Wang, J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.017 · Cited by 86
“It has been shown that senile plaques are a pathologic hallmark of AD and are composed of -amyloid (A ), activated microglia, astrocytes, and degenerating neurons (Giulian et al., 1995; Itagaki et al., 1989; Sasaki et al., 1997; Streit et al., 2004).”
Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation
Familian, A., Boshuizen, R. S., Eikelenboom, P., & Veerhuis, R. (2006) · Glia · doi:10.1002/glia.20268 · Cited by 85
“Deposition of Ab is considered a neuropathological hallmark of AD and is associated with clusters of activated microglia in AD affected brain areas (Sasaki et al., 1997; Veerhuis et al., 2003; Blasko et al., 2004; Veerhuis et al., 2004).”
BackgroundSasaki, A., Kawarabayashi, T., Murakami, T., Matsubara, E., Ikeda, M., Hagiwara, H., Westaway, D. A., George‐Hyslop, P. S., Shoji, M., & Nakazato, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.084 · Cited by 82
Self-citationMortadza, S. A. S., Sim, J. A., Stacey, M. A., & Jiang, L. (2017) · Scientific Reports · doi:10.1038/srep45032 · Cited by 74
Jung, H. W., Son, H. Y., Minh, C. V., Kim, Y. H., & Park, Y. (2008) · Phytotherapy Research · doi:10.1002/ptr.2442 · Cited by 76
“Indeed, these cytokines are abundantly induced in brain microglia by stimulants such as IFN-γ, amyloid-β (Sasaki et al., 1997), gangliosides (Pyo et al., 1999), thrombin (Choi et al., 2003), metalloproteinase 3 (Kim et al., 2005) and LPS (Appel et al., 1995).”
BackgroundNeuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update
Gouilly, D., Saint‐Aubert, L., Ribeiro, M., Salabert, A., Tauber, C., Péran, P., Arlicot, N., Pariente, J., & Payoux, P. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15613 · Cited by 63
“Two neuropathological studies described clustered microglia around amyloid deposits in the cerebellum, but morphological features of activation were observed only in the vicinity of compact aggregates and not around diffuse deposits (Mattiace et al., 1990; Sasaki et al., 1997).”
BackgroundIsolation and Characterization of Apolipoproteins from Murine Microglia
Xu, Q., Li, Y., Cyras, C., Sanan, D. A., & Cordell, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002796200 · Cited by 69
Ringheim, G. E., & Conant, K. E. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.013 · Cited by 73
“The presence of IL-1a-positive, MHCII-positive, slightly enlarged microglia in these early diffuse plaques indicates, however, that the beginning stages of cellular transformation into an activated proinflammatory state are occurring (Griffin et al., 1995; Sasaki et al., 1997).”
BackgroundHu, W., Wu, F., Zhang, Y., Gong, C.-X., Iqbal, K., & Liu, F. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00311 · Cited by 58
“In AD brain, accompanying neurodegeneration, microglia are overactivated and play important roles in AD pathogenesis (Mattiace et al., 1990; Sasaki et al., 1997; Wes et al., 2016; Leyns and Holtzman, 2017).”
BackgroundSasaki, A., Shoji, M., Harigaya, Y., Kawarabayashi, T., Ikeda, M., Naito, M., Matsubara, E., Abe, K., & Nakazato, Y. (2002) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-002-0643-8 · Cited by 69
“Activated microglia were consistently observed in primitive and classic plaques in the brains of AD patients [16, 21, 25].”
BackgroundSelf-citationInflammation and Microglia Actions in Alzheimer’s Disease
Combs, C. K. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9165-3 · Cited by 70
Autotransplantation of Bone Marrow-Derived Stem Cells as a Therapy for Neurodegenerative Diseases
Kan, I., Melamed, E., & Offen, D. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68976-8_10 · Cited by 64
Kelly, R. L., Joers, V. L., Tansey, M. G., McKernan, D. P., & Dowd, E. (2020) · Molecules · doi:10.3390/molecules25030453 · Cited by 59
Tsatsanis, A., McCorkindale, A. N., Wong, B. X., Patrick, E., Ryan, T. M., Evans, R. W., Bush, A. I., Sutherland, G. T., Sivaprasadarao, A., Guennewig, B., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01248-1 · Cited by 56
The executioners sing a new song: killer caspases activate microglia
Venero, J. L., Burguillos, M. Á., Brundin, P., & Joseph, B. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.107 · Cited by 60
Increased tauopathy drives microglia-mediated clearance of beta-amyloid
Chen, W., Abud, E. A., Yeung, S. T., Lakatos, A., Nassi, T., Wang, J., Blum, D., Buée, L., Poon, W. W., & Blurton-Jones, M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0336-1 · Cited by 52
“vantage over predominately intracellular tau aggregates in its potential influence over microglial activation as evident of amyloid soluble oligomers released from abundant extracellular plaques [55, 70, 77].”
BackgroundHorikoshi, Y., Sasaki, A., Taguchi, N., Maeda, M., Tsukagoshi, H., Sato, K., & Yamaguchi, H. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0627-4 · Cited by 61
“Microglia have been demonstrated using macrophagedirected antibodies KP-1, Ki-M1p and CR3.43 [6, 12, 15, 18, 19 ].”
BackgroundMethodSelf-citationEffects of chronic low dose rotenone treatment on human microglial cells
Shaikh, S. B., & Nicholson, L. F. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-55 · Cited by 51
“CR3/43 protein is specifically expressed in activated microglia and is therefore used as a marker for activated microglia [65,66].”
Lull, M. E., Levesque, S., Surace, M. J., & Block, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020153 · Cited by 49
“neurofibrillary tangles [10,16], become activated [17], and”
Synaptoimmunology - roles in health and disease
Nisticò, R., Salter, E., Nicolas, C., Feligioni, M., Mango, D., Bortolotto, Z. A., Gressens, P., Collingridge, G. L., & Peineau, S. (2017) · Molecular Brain · doi:10.1186/s13041-017-0308-9 · Cited by 52
Codocedo, J. F., Mera-Reina, C., Bor-Chian Lin, P., Fallen, P. B., Puntambekar, S. S., Casali, B. T., Jury-Garfe, N., Martinez, P., Lasagna-Reeves, C. A., & Landreth, G. E. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114488 · Cited by 52
Molecular and cellular mediators of Alzheimer's disease inflammation
Strohmeyer, R., & Rogers, J. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3118 · Cited by 51
“Such a possibility is supported by many studies [76,141,248,353,427], including ultrastructural observations consistent with the possibility that microglia may participate in the laying down of amyloid fibrils within plaques [445].”
Zhong, L., Jiang, X., Zhu, Z., Qin, H., Dinkins, M. B., Kong, J., Leanhart, S., Wang, R., Elsherbini, A. M., Bieberich, E., et al. (2018) · Glia · doi:10.1002/glia.23558 · Cited by 55
von Bernhardi, R., Ramírez, G., Toro, R., & Eugenín, J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.006 · Cited by 50
Anti-inflammatory drugs: a hope for Alzheimer’s disease?
Hüll, M., Lieb, K., & Fiebich, B. L. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.671 · Cited by 60
“First of all, diffuse amyloid plaques contain resting ramified microglial cells without signs of activation in non-demented controls [27,29].”
BackgroundGatson, J. W., Warren, V., Abdelfattah, K., Wolf, S., Hynan, L. S., Moore, C., Diaz-Arrastia, R., Minei, J. P., Madden, C., & Wigginton, J. G. (2013) · Journal of Neurosurgery · doi:10.3171/2013.2.jns121771 · Cited by 47
Role of Microglia in Age-Related Changes to the Nervous System
Brown, D. R. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.111 · Cited by 49
“Deposition of Aβ in plaques is associated with both recruitment and activation of microglia[12,57,58].”
BackgroundActivation of Human Macrophages by Amyloid-β Is Attenuated by Astrocytes
Smits, H. A., van Beelen, A. J., de Vos, N. M., Rijsmus, A., van der Bruggen, T., Verhoef, J., van Muiswinkel, F. L., & Nottet, H. S. L. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6869 · Cited by 46
Viel, J. J., McManus, D. Q., Smith, S. S., & Brewer, G. J. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1097 · Cited by 52
“Microglia have been shown to surround dense core plaques, and are also implicated in the processing of bAPP and deposition of Ab (Paresce et al., 1996; Sasaki et al., 1997).”
BackgroundThe cAMP-specific phosphodiesterase 4B mediates Aβ-induced microglial activation
Sebastiani, G., Morissette, C., Lagacé, C., Boulé, M., Ouellette, M., McLaughlin, R. W., Lacombe, D., Gervais, F., & Tremblay, P. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.024 · Cited by 45
Solga, A. C., Pong, W. W., Walker, J., Wylie, T., Magrini, V., Apicelli, A. J., Griffith, M., Griffith, O. L., Kohsaka, S., Wu, G. F., et al. (2015) · Glia · doi:10.1002/glia.22754 · Cited by 40
“, 2012), Alzheimer’s disease (Davis et al., 1992; Meda et al., 1995; Sasaki et al., 1997), and traumatic brain injury (TBI; Hernandez-Ontiveros et al.”
AGEs–RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells
Shaikh, S. B., Uy, B., Perera, A., & Nicholson, L. F. B. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.02.023 · Cited by 45
Toxic stress, inflammation and symptomatology of chronic complications in diabetes
Downs, C. A., & Faulkner, M. S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.554 · Cited by 42
Microglia and Other Myeloid Cells in Central Nervous System Health and Disease
Gopinath, A., Collins, A., Khoshbouei, H., & Streit, W. J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265058 · Cited by 44
Expression of glucose transporter 5 by microglia in human gliomas
Sasaki, A., Yamaguchi, H., Horikoshi, Y., Tanaka, G., & Nakazato, Y. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00556.x · Cited by 43
Self-citationRelationship between β-AP peptide aggregation and microglial activation
Casal, C., Serratosa, J., & Tusell, J. M. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03362-5 · Cited by 42
Tauber, S. C., Ebert, S., Weishaupt, J. H., Reich, A., Nau, R., & Gerber, J. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b7fde5 · Cited by 39
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 46
Aβ peptide conformation determines uptake and interleukin-1α expression by primary microglial cells
Parvathy, S., Rajadas, J., Ryan, H. S., Vaziri, S., Anderson, L., & Murphy, G. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.011 · Cited by 43
Complement C1q expression induced by Aβ in rat hippocampal organotypic slice cultures
Fan, R., & Tenner, A. J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.023 · Cited by 34
Masumura, M., Hata, R., Nishimura, I., Uetsuki, T., Sawada, T., & Yoshikawa, K. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00163-7 · Cited by 39
Su, Y., Ganea, D., Peng, X., & Jonakait, G. M. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00397-1 · Cited by 38
The secretases of Alzheimer's disease
Wolfe, M. S. (2003) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(03)54011-x · Cited by 35
Herr, D., Jew, K., Wong, C., Kennell, A., Gelein, R. M., Chalupa, D., Raab, A., Oberdörster, G., Olschowka, J. A., O’Banion, M. K., et al. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.03.010 · Cited by 36
The emerging role of disease-associated microglia in Parkinson’s disease
Samant, R. R., Standaert, D. G., & Harms, A. S. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1476461 · Cited by 36
“For example, within AD, the accumulation of amyloid plaques leads to microglial clustering and activation (Sasaki et al., 1997).”
Frontiers in Alzheimer’s disease therapeutics
Stone, J. G., Casadesús, G., Rothenberg, K. G., Siedlak, S. L., Wang, X., Zhu, X., Perry, G. L., Castellani, R. J., & Smith, M. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310382817 · Cited by 34
“…Wegiel et al. 2001], suggest microglia assist in conversion of Ab to its fibrillar form, induce diffuse plaques to aggregate into neuritic plaques [Sasaki et al. 1997; Cotman et al. 1996; Griffin et al. 1995; Mackenzie et al. 1995], and induce glutamate release contributing to excitotoxicity…”
BackgroundDiminished Production of Proinflammatory Cytokines in Patients with Alzheimer’s Disease
Richartz, E., Batra, A., Simon, P. D., Wormstall, H., Bartels, M., Buchkremer, G., & Schott, K. J. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000083497 · Cited by 32
A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes
Heininger, K. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199912)14:8<525::aid-hup140>3.0.co;2-t · Cited by 30
“…microglia seems to increase along the stages of plaque maturation, is ®rst detectable at the transition between di use and primitive plaques and progresses to clusters of activated microglia in classic plaques [Sasaki et al., 1997] paralleled by the neuritic transformation of SPs [Su et al., 1998].”
BackgroundAnti-inflammatory substances – a new therapeutic option in Alzheimer's disease
Hüll, M. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01339-2 · Cited by 30
Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation
Baby, N., Patnala, R., Ling, E., & Dheen, S. T. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140716101258 · Cited by 26
Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain
Streit, W. J., Xue, Q., Braak, H., & del Tredici, K. (2014) · Glia · doi:10.1002/glia.22589 · Cited by 24
“…for harmful inflammation in AD neurodegeneration are, (a) presence of HLA-DR-positive microglia (McGeer et al., 1987), (b) presence of microglial clusters around Ab deposits (Sasaki et al., 1997), and (c) presence of interleukin-1 (IL-1) immunoreactivity (Griffin et al., 1989; Sheng et al., 1997).”
BackgroundPeripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 25
Ulaganathan, S., & Pitchaimani, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121918 · Cited by 25
Smits, H. A., Vos, N., Wat, J. W. Y., van der Bruggen, T., Verhoef, J., & Nottet, H. S. L. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00254-5 · Cited by 23
Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions
Tu, J., Chen, B., Yang, L., Qi, K., Lu, J. N., & Zhao, D. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0553-2 · Cited by 24
Harun, A., Vidyadaran, S., Lim, S. M., Cole, A. L. J., & Ramasamy, K. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0685-5 · Cited by 24
“IFN-γ, amyloid-β [38].”
Silva, K. D., Brown, M. E., Westaway, D. A., & McLaurin, J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.013 · Cited by 25
Metadata
- Authors
- Sasaki, A., Yamaguchi, H., Ogawa, A., Sugihara, S., & Nakazato, Y.
- Affiliations
- Gunma University (JP)
- Gunma Prefectural Cancer Center (JP)
- ORCID
- Sasaki, A.
- Venue
- Acta Neuropathologica
- Published
- 1997-10-12
- Volume
- 94
- Issue
- 4
- Pages
- 316-322
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1994360125
- Cited by
- 132
- References
- 33
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 7 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- microglial activation, Alzheimer's disease, diffuse plaques, MHC class II, amyloid precursor protein, cerebellum, cerebral cortex
- MeSH terms
- Aged, Alzheimer Disease, Cerebellum, Cerebral Cortex, Humans, Immunohistochemistry, Middle Aged, Amyloid beta-Peptides, Microglia, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.